ARTG 410692MRI contrast medium injection system, battery-powered
ARTG ID: 410692 · Imaxeon Pty Ltd · Bayer Medical Care Inc · Class IIb · Started June 16, 2023
Good Name: Imaxeon Pty Ltd - MRI contrast medium injection system, battery-powered
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 410692
- Start Date
- June 16, 2023
- Effective Date
- June 16, 2023
- Name
- Imaxeon Pty Ltd
- Country
- United States of America
- Address
- 1 Bayer Drive, Indianola, PA, 15051-0780
This system is intended for the purposes of injecting intravenous MR contrast media and common flushing solutions into the human vascular system for diagnostic studies in magnetic resonance imaging (MRI) procedures
Access comprehensive regulatory information for MRI contrast medium injection system, battery-powered in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 410692 and sponsored by Imaxeon Pty Ltd, manufactured by Bayer Medical Care Inc in United States of America. The device registration started on June 16, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.